A study found that 26% of uncertainties in cancer drug approvals are not included in FDA labels, with 48% being crucial to approval decisions. The FDA's current communication methods, such as drug ...

These results suggest that “clinicians may be unaware of important clinical trial limitations identified by the FDA when making prescribing decisions." A majority of cancer drugs approved in the US ...

As greenhouse gases pour into the atmosphere, global temperatures rise smoothly and predictably in response. It’s the fundamental basis of climate change, the physical law that’s been reshaping the ...

Please provide your email address to receive an email when new articles are posted on . The FDA frequently identifies uncertainties about newly approved cancer drugs, but they are often omitted in ...

FDA reviewers flagged trial uncertainties for nearly 80% of cancer drugs approved from 2019 to 2022, but few were reported in journals or National Comprehensive Cancer Network (NCCN) guidelines. The ...

Resilience, adaptability, and self-love are vital in leading through change. Prioritizing mental and emotional well-being fosters a culture of adaptability and enhances job satisfaction, leading to ...